期刊文献+

脓毒症患者血清胆红素水平与急性呼吸窘迫综合征发生率及病死率的相关性研究 被引量:2

暂未订购
导出
摘要 目的:探讨脓毒症患者血清胆红素水平与急性呼吸窘迫综合征(ARDS)发生率和病死率的相关性。方法:收治近3年确诊为脓毒症患者86例。利用受试者工作特征曲线(ROC)综合分析胆红素水平对脓毒症并发ARDS患者的诊断价值。应用Logistic回归分析胆红素水平与脓毒症并发ARDS的危险度。结果:ARDS组中,死亡患者入科时总胆红素和直接胆红素水平[(36.1±22.5)μmol/L,(11.2±10.9)μmol/L]均高于存活患者[(26.6±15.1)μmol/L,(8.9±5.2)μmol/L](总胆红素P<0.05),死亡患者在诊断ARDS当天血清总胆红素水平明显高于存活组患者[(46.8±18.3)μmol/L vs(33.8±19.2)μmol/L,(P<0.05)]。诊断ARDS当天的总胆红素水平对于ARDS的诊断有中等程度的诊断价值(AUC=0.689,P=0.013)。在入住ICU时,血清总胆红素水平每升高1 mg/d L,ARDS发生风险增加51%(OR=1.51,P=0.031),死亡风险增加68%(OR=1.68,P=0.012)。诊断ARDS时,血清总胆红素水平每升高1 mg/d L,死亡风险增加167%(OR=2.67,P=0.008)。结论:脓毒症患者的胆红素水平与ARDS的发生以及病情预后密切相关。
出处 《内科急危重症杂志》 2015年第4期301-303,共3页 Journal of Critical Care In Internal Medicine
  • 相关文献

参考文献9

二级参考文献36

  • 1Sheu CC, Gong MN, Zhai R, et al. Clinical characteristics and out-comes of sepsis - related vs non - sepsis - related ARDS [ J]. Chest,2010,138(3):559 -567.
  • 2Fukuda Y. Acute lung injury/acute respiratory distress syndrome: pro-gress in diagnosis and treatment. Topics: I. Pathogenesis and patho-physiology :4. Pathophysiology and histopathology of AT,T/ARDS[ J].Nihon Naika Gakkai zasshi, 2011,100(6) : 1536 - 1540.
  • 3Janz DR, Ware LB. Biomarkere of ALI/AKDS: Pathogenesis, Discov-ery ,and Relevance to Clinical Trials. Seminars in respiratory and criticalcare medicine[ J]. Semin Respir Crit Care Med, 2013,34(4) :537 -548.
  • 4Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign:international guidelines for management of severe sepsis and septicshock: 2012[J]. Crit Care Med, 2013,41(2) :580 -637.
  • 5ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, ThompsonBT,et al. Acute respiratory distress syndrome : the Berlin Definition[J]. JAMA, 2012,307(23):2526 -2533.
  • 6Willems CH,Zimmermann LJ,Langen RM,et al. Surfactant protein Ainfluences reepithelialization in an alveolocapillary model system [ J],Lung,2012,190(6) :661 -669.
  • 7Liamina SV, Shimshelashvili ShL, Malyshev IIu. Surfactant protein Dendogenous regulator of inflammation and immune defense [ J]. Patol Fi-ziol Eksp Ter, 2012,(1) :60 -66..
  • 8Shrive AK, Martin C, Bums I,et al. Structural characterisation of lig-and -binding determinants in human lung surfactant protein D: influenceof AsP325[J]. J Mol Biol, 2009,394(4) :776 -788.
  • 9Boonarkart CH, Suptawiwat 0,Uiprasertkul M. A reduced expressionof surfactant protein D in the lungs of fatal influenza H1N1 cases in 2009[J]. Acta Virol, 2012,56(3) :253 -255.
  • 10Gaunsbaek MQ, Rasmussen KJ, Beers MF, et al, Lung surfactant pro-tein D ( SP - D) response and regulation during acute and chronic lunginjury[ J]. Lung, 2013,191 (3) :295 -303.

共引文献44

同被引文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部